| 000 | 01118cam a2200253 4500 | ||
|---|---|---|---|
| 001 | 1635930200 | ||
| 008 | 190306t2019 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a1635930200 | ||
| 020 | _a9781635930207 | ||
| 100 | _aOlsen, Mikaela, M. (ed) | ||
| 245 | 0 | _aChemotherapy and Immunotherapy Guidelines and Recommendations for Practice | |
| 260 |
_aPittsburgh : _bOncology Nursing Society, _c2019 |
||
| 505 | _aProfessional practice considerations; Cancer and cancer treatment; Cancer therapeutics; Treatment administration and safety; Treatment-related complications; Post-treatment; Appendices | ||
| 520 | _aChemotherapy and Immunotherapy Guidelines and Recommendations for Practice features 26 chapters examining multiple categories of cancer-care agents, including chemotherapy, immunotherapy, molecularly targeted agents, and hormone therapy. | ||
| 650 | _aChemotherapy | ||
| 650 |
_aImmunotherapy _96577 |
||
| 650 | _aGuidelines | ||
| 690 | _aCHEMOTHERAPY | ||
| 690 |
_aImmunotherapy _96577 |
||
| 700 | _aLeFebvre, Kristine, B. (ed) | ||
| 700 | _aBrassil, Kelly, J. (ed) | ||
| 999 |
_c40263 _d40263 |
||
| 942 | 0 | 0 | _01 |